中晚期肝癌的非手术综合治疗  

Non-surgical Comprehensive Treatment for Advanced Liver Cancer

作　　者：李书有 LI Shu-you(Department of Oncology,Wuming Hospital Affiliated to Guangxi Medical University,Nanning 530199,Guangxi,China)

机构地区：[1]广西医科大学附属武鸣医院肿瘤科,广西南宁530199

出　　处：《医学信息》2022年第9期73-75,80,共4页Journal of Medical Information

摘　　要：肝细胞癌(HCC)是我国最常见的恶性肿瘤,其发病隐匿、进展较快,患者在确诊时多处于疾病中晚期阶段,以非手术治疗为主。目前,中晚期肝癌的治疗方案包括血管介入治疗、靶向治疗、免疫治疗、放疗及消融治疗等,但单一应用尚存在较大局限性。对此,临床现已将综合治疗作为肝癌疾病的治疗共识,旨在为中晚期肝癌提供更佳的治疗选择。Hepatocellular carcinoma(HCC)is the most common malignant tumor in China.The incidence of HCC is occult and the progress is rapid.Most patients are in the middle and late stages of the disease when diagnosed,and non-surgical treatment is the main treatment.At present,the treatment of advanced liver cancer includes vascular interventional therapy,targeted therapy,immunotherapy,radiotherapy and ablation therapy,but there are still great limitations in single application.In this regard,comprehensive treatment has been regarded as a consensus for the treatment of liver cancer in clinic,aiming to provide better treatment options for advanced liver cancer.

关 键 词：中晚期肝癌 血管介入治疗 免疫治疗 靶向治疗 消融治疗 

分 类 号：R753.7[医药卫生—皮肤病学与性病学]